Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy
Status:
Unknown status
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Recent studies have established the reliability, validity and time course of the cannabis
withdrawal syndrome. This study will investigate the effects of combined treatment of
Escitalopram with cognitive-behavior therapy in alleviating the symptoms of the marijuana
withdrawal syndrome in regular chronic users of marijuana. We predict that combined
pharmacological treatment and cognitive-behavior therapy will help patients to abstain from
using using marijuana and it will alleviate their marijuana withdrawal symptoms.